Domestic drug prices lower at 48% of 7 advanced countries.

The Korea Pharmaceutical Manufacturers Association (KPMA) reported that the average price of the top 300 prescription drugs reimbursed by the NHI scheme in 2003 showed at the level of 48% of the 7 advanced countries in 2004, indicating that the domestic drugs were devalued at 32% in low and 63% in high.

The price levels in other advanced countries showed 3 times higher in the United States ...